Committee of the health insurance and legislation
KDA and HIRA joint symposium: about practical reviews and assessment
5월 7일 (목) 15:00~17:00
Room 5
서기현
(건강보험심사평가원)
CS1-1
The process of review and the development of healthcare benefit standard in HIRA
박혜경
(건강보험심사평가원)
CS1-2
Artificial intelligence electronic review
김수경
(CHA 의과학대 내과)
CS1-3
Clinical significance of laboratory tests in diabetic patients
김덕호
(건강보험심사평가원)
CS1-Panel 1
하상미
(건강보험심사평가원)
CS1-Panel 2
윤순희
(건강보험심사평가원)
CS1-Panel 3
김난희
(고려의대 내과)
CS1-Panel 4
윤석기
(천안 엔도내과)
CS1-Panel 5
박석오
(광명성애병원 내과)
CS1-Panel 6
Committee of clinical practice guideline
Korean Diabetes Association 2015 guidelines: a preview
5월 8일 (금) 09:00~10:40
Room 3
좌장: 허갑범, 안유헌
차봉수
(연세의대 내과)
CS2-1
New treatment guideline strategy in 2015 edition
김대중
(아주의대 내과)
CS2-2
Glycemic targets and assessment of glycemic control
고승현
(가톨릭의대 내과)
CS2-3
Clinical practice guideline 2015 KDA: oral hypoglycemic agents in type 2 diabetes mellitus
이원영
(성균관의대 내과)
CS2-4
Clinical practice guideline 2015 KDA : injection treatment in type 2 diabetes mellitus
김재현
(성균관의대 내과)
CS2-5
Updated guideline for Korean adults with type 1 diabetes
KDA research group on metabolic syndrome
PPARgamma revisited
5월 9일 (토) 09:00~11:00
Room 5-2
좌장: 이문규, 장학철
서성환
(동아의대 내과)
RG1
Metabolic syndrome and cardiovascular disease in Korea
정창희
(울산의대 내과)
RG2
Is metabolically healthy obesity a benign condition? focusing on Korean data
김난희
(고려의대 내과)
RG3
Metabolic syndrome, fatty liver, and cardiovascular changes
김성래
(가톨릭의대 내과)
RG4
Metabolic syndrome, dyslipidemia, and cardiovascular disease
